Patompong Ungprasert1, Cynthia S Crowson2,3, Eric L Matteson2,4. 1. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First avenue SW, Rochester, MN, 55905, USA. P.Ungprasert@gmail.com. 2. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First avenue SW, Rochester, MN, 55905, USA. 3. Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN, 55905, USA. 4. Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, MN, 55905, USA.
Abstract
PURPOSE: The influence of ethnicity on epidemiology and clinical manifestations of sarcoidosis is well recognized. However, data on the role of sex are limited. METHODS: The current study utilized the resource of the Rochester Epidemiology Project to identify all residents of Olmsted County, Minnesota, United States, with new diagnosis of sarcoidosis from 1976 to 2013. Diagnosis was verified by medical record and histopathological report review. RESULTS: 345 incident cases of sarcoidosis were identified: 174 (50 %) were female and 171 (50 %) were male. The age at diagnosis was significantly higher among females than males (48.3 vs. 42.8 years; p < 0.001). Intra-thoracic disease was seen in the great majority of patients (98 % among females and 96 % among males; p = 0.50). However, pulmonary symptoms were significantly more frequent among males than females (51 vs. 36 %; p = 0.006). The frequency of individual extra-thoracic organ involvement was not significantly different between females and males except for cutaneous involvement and uveitis that were significantly more common among females (6 vs. 1 % for uveitis, p = 0.012 and 25 vs. 12 % for cutaneous involvement, p = 0.002). The frequency of elevate angiotensin-converting enzyme level and hypercalcemia was not significantly different between the two sexes. CONCLUSIONS: Females tended to be older at the age they developed sarcoidosis, and had more uveitis and cutaneous involvement than males.
PURPOSE: The influence of ethnicity on epidemiology and clinical manifestations of sarcoidosis is well recognized. However, data on the role of sex are limited. METHODS: The current study utilized the resource of the Rochester Epidemiology Project to identify all residents of Olmsted County, Minnesota, United States, with new diagnosis of sarcoidosis from 1976 to 2013. Diagnosis was verified by medical record and histopathological report review. RESULTS: 345 incident cases of sarcoidosis were identified: 174 (50 %) were female and 171 (50 %) were male. The age at diagnosis was significantly higher among females than males (48.3 vs. 42.8 years; p < 0.001). Intra-thoracic disease was seen in the great majority of patients (98 % among females and 96 % among males; p = 0.50). However, pulmonary symptoms were significantly more frequent among males than females (51 vs. 36 %; p = 0.006). The frequency of individual extra-thoracic organ involvement was not significantly different between females and males except for cutaneous involvement and uveitis that were significantly more common among females (6 vs. 1 % for uveitis, p = 0.012 and 25 vs. 12 % for cutaneous involvement, p = 0.002). The frequency of elevate angiotensin-converting enzyme level and hypercalcemia was not significantly different between the two sexes. CONCLUSIONS: Females tended to be older at the age they developed sarcoidosis, and had more uveitis and cutaneous involvement than males.
Entities:
Keywords:
Clinical manifestation; Epidemiology; Sarcoidosis; Sex
Authors: Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack Journal: Am J Respir Crit Care Med Date: 2004-09-03 Impact factor: 21.405
Authors: Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; David M Serlin; Lynn Rosenberg Journal: Chest Date: 2010-07-01 Impact factor: 9.410
Authors: Marc A Judson; Amit Chopra; Edward Conuel; Efstratios Koutroumpakis; Christopher Schafer; Adam Austin; Robert Zhang; Kerry Cao; Rani Berry; Malik M H S Khan; Aakash Modi; Ritu Modi; Stephanie Jou; Furqan Ilyas; Recai M Yucel Journal: Lung Date: 2017-07-13 Impact factor: 2.584
Authors: Fatima Alnaimat; Khaled Al Oweidat; Anas Alrwashdeh; Ahmad Alnashrati; Saba Barham; Mohammad Hijaz; Dina Murad; Sameeha Alshelleh; Nathir Obeidat Journal: Arch Rheumatol Date: 2020-02-07 Impact factor: 1.472
Authors: Antonio De Cinque; Beniamino Corcioni; Martina Sofia Rossi; Alessandro Franceschelli; Fulvio Colombo; Rita Golfieri; Matteo Renzulli; Caterina Gaudiano Journal: Front Med (Lausanne) Date: 2021-01-27
Authors: Łukasz Gwadera; Adam Jerzy Białas; Mikołaj Aleksander Iwański; Paweł Górski; Wojciech Jerzy Piotrowski Journal: Chron Respir Dis Date: 2019 Jan-Dec Impact factor: 2.444